New TB testing method uses skin bacteria to speed up drug development
NCT ID NCT05592223
First seen Jan 04, 2026 · Last updated May 16, 2026 · Updated 21 times
Summary
This study aimed to create a human challenge model for tuberculosis (TB) using a harmless bacteria called BCG. Twenty healthy adults received BCG under the skin to see how the body fights it and how TB drugs might work. The goal is to test new TB vaccines and treatments faster and more safely in early-phase trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUBERCULOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fred Hutchinson Cancer Center
Seattle, Washington, 98109, United States
Conditions
Explore the condition pages connected to this study.